197 related articles for article (PubMed ID: 30097435)
1. Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.
Tran TH; Utama FE; Sato T; Peck AR; Langenheim JF; Udhane SS; Sun Y; Liu C; Girondo MA; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Palazzo JP; Bibbo M; Auer PW; Flister MJ; Hyslop T; Mitchell EP; Chervoneva I; Rui H
Clin Cancer Res; 2018 Dec; 24(24):6355-6366. PubMed ID: 30097435
[TBL] [Abstract][Full Text] [Related]
2. PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development.
Grinman DY; Boras-Granic K; Takyar FM; Dann P; Hens JR; Marmol C; Lee J; Choi J; Chodosh LA; Sola MEG; Wysolmerski JJ
Breast Cancer Res; 2022 Apr; 24(1):30. PubMed ID: 35440032
[TBL] [Abstract][Full Text] [Related]
3. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
[TBL] [Abstract][Full Text] [Related]
4. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 5a inhibited by pimozide may regulate survival of goat mammary gland epithelial cells by regulating parathyroid hormone-related protein.
Li H; Zheng H; Sun Y; Yu Q; Li L
Gene; 2014 Nov; 551(2):279-89. PubMed ID: 25194899
[TBL] [Abstract][Full Text] [Related]
6. Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.
Yang N; Liu C; Peck AR; Girondo MA; Yanac AF; Tran TH; Utama FE; Tanaka T; Freydin B; Chervoneva I; Hyslop T; Kovatich AJ; Hooke JA; Shriver CD; Rui H
Breast Cancer Res; 2013; 15(5):R73. PubMed ID: 24004716
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
8. Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.
Peck AR; Witkiewicz AK; Liu C; Klimowicz AC; Stringer GA; Pequignot E; Freydin B; Yang N; Ertel A; Tran TH; Girondo MA; Rosenberg AL; Hooke JA; Kovatich AJ; Shriver CD; Rimm DL; Magliocco AM; Hyslop T; Rui H
Breast Cancer Res; 2012 Oct; 14(5):R130. PubMed ID: 23036105
[TBL] [Abstract][Full Text] [Related]
9. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.
Barcus CE; O'Leary KA; Brockman JL; Rugowski DE; Liu Y; Garcia N; Yu M; Keely PJ; Eliceiri KW; Schuler LA
Breast Cancer Res; 2017 Jan; 19(1):9. PubMed ID: 28103936
[TBL] [Abstract][Full Text] [Related]
10. Calcium-Sensing Receptor Promotes Breast Cancer by Stimulating Intracrine Actions of Parathyroid Hormone-Related Protein.
Kim W; Takyar FM; Swan K; Jeong J; VanHouten J; Sullivan C; Dann P; Yu H; Fiaschi-Taesch N; Chang W; Wysolmerski J
Cancer Res; 2016 Sep; 76(18):5348-60. PubMed ID: 27450451
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
12. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
Linher-Melville K; Singh G
BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
[TBL] [Abstract][Full Text] [Related]
14. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
[TBL] [Abstract][Full Text] [Related]
15. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis.
Bouizar Z; Spyratos F; De vernejoul MC
J Bone Miner Res; 1999 Mar; 14(3):406-14. PubMed ID: 10027905
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.
Gilmore JL; Scott JA; Bouizar Z; Robling A; Pitfield SE; Riese DJ; Foley J
Breast Cancer Res Treat; 2008 Aug; 110(3):493-505. PubMed ID: 17882547
[TBL] [Abstract][Full Text] [Related]
17. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
Craig JM; Turner TH; Harrell JC; Clevenger CV
Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome.
Xu C; Wang Z; Cui R; He H; Lin X; Sheng Y; Zhang H
BMC Cancer; 2015 Nov; 15():925. PubMed ID: 26597083
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells.
Ibaragi S; Shimo T; Iwamoto M; Hassan NM; Kodama S; Isowa S; Sasaki A
Anticancer Res; 2010 Dec; 30(12):5029-36. PubMed ID: 21187486
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
